Compound information
- Natural Products
- ZC3283734
- Molecular Formula
- C28H46N2O5
- Molecular Weight
- 490.340672572 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-(benzyloxycarbonylamino)-6-(tetradecanoylamino)hexanoic acid
- InChI
- InChI=1S/C28H46N2O5/c1-2-3-4-5-6-7-8-9-10-11-15-21-26(31)29-22-17-16-20-25(27(32)33)30-28(34)35-23-24-18-13-12-14-19-24/h12-14,18-19,25H,2-11,15-17,20-23H2,1H3,(H,29,31)(H,30,34)(H,32,33)/t25-/m0/s1
- InChI Key
- XXFBWMHPFLUIES-VWLOTQADSA-N
- SMILES
- CCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC001615773648
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 35 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 21 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 104.73 Å2 | LogP | 6.552 |
LogS | -4.362 | LogD | 3.988 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.021 |
HIA | 0.526 | F20 % | 0.633 |
F30 % | 0.0 | Caco-2 | -5.513 |
MDCK | -5.557 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.013 | PPB | 95.399 |
VD | 0.449 | Fu | 2.614 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.627 | CYP1A2 substrate | 0.315 |
CYP2A6 substrate | 0.277 | CYP2B6 substrate | 0.418 |
CYP2C19 inhibitor | 0.114 | CYP2C19 substrate | 0.486 |
CYP2C8 substrate | 0.526 | CYP2C9 inhibitor | 0.127 |
CYP2C9 substrate | 0.078 | CYP2D6 inhibitor | 0.43 |
CYP2D6 substrate | 0.182 | CYP2E1 substrate | 0.282 |
CYP3A4 inhibitor | 0.296 | CYP3A4 substrate | 0.239 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.752 | CL | 3.98 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.007 | Hepatotoxicity | 0.496 |
Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.018 |
FDAMDD | 0.059 | Skin Sensitization | 0.912 |
Carcinogenicity | 0.112 | Eye Corrosion | 0.002 |
Eye Irritation | 0.02 | Respiratory Toxicity | 0.019 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.23 | IGC50 | 5.5 |
LC50FM | 3.434 | LC50DM | 5.524 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.341 | NR-AR-LBD | 0.22 |
NR-AhR | 0.004 | NR-Aromatase | 0.051 |
NR-ER | 0.37 | NR-ER-LBD | 0.355 |
NR-PPAR-gamma | 0.799 | SR-ARE | 0.457 |
SR-ATAD5 | 0.298 | SR-HSE | 0.224 |
SR-MMP | 0.1 | SR-p53 | 0.207 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.